EDITORIAL SECTION

Articles

Why Leading Pharma Professionals Rely on the Pharma Focus Europe E-Newsletter

The network of the pharmaceutical and life sciences in Europe is undergoing a radical transformation There are changes in the regulatory environments a rise in the pace of innovation a shift in leadership and a change in the distribution production and development of therapies by the use of digital technologies In this environment no longer will access to timely credible and context rich informati...

Cold Chain Logistics for Pharmaceuticals: A Complete Guide to Compliance, Technology, and Best Practices

In the pharmaceutical industry preserving the integrity of temperaturesensitive products is crucial Cold chain logistics for pharmaceuticals play a vital role in ensuring that vaccines biologics and other temperaturesensitive medicines reach patients safely and effectively This complete guide explores pharmaceutical cold chain management focusing on compliance innovative technology and industry be...

Exploring the Benefits of Sustainable Clinical Trials

The landscape of clinical trials is evolving with a growing recognition that research endeavors should extend beyond scientific excellence to encompass broader societal environmental and economic considerations

Smarter, Faster, Cheaper: The Quiet Revolution in Pharma's First Half of 2026

If you took a step back to look at the pharmaceutical industry during the first six months of one thing became obvious very quickly The old rules of global drug manufacturing were quietly rewritten For decades major lowcost production centers were viewed mostly as highvolume factories for basic

Globalization of Pharma Operations: Opportunities and Challenges for European Companies

The globalization of pharmaceutical operations for European companies marks a pivotal strategic shift reflecting a historical evolution that has unfolded over time Understanding the context of this transformative journey is essential

Adaptive Trial Designs: Enhancing Speed and Decision-Making in Clinical Development

For decades the traditional clinical trial has followed a rigid script A protocol is written patients are enrolled the study runs to completion and only at the very end does the sponsor learn whether the investment paid off The model has served the industry well in terms of scientific rigour

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys